CVD Risk of Hypertension. Regina Giblin CVD Clinical Development Coordinator

Size: px
Start display at page:

Download "CVD Risk of Hypertension. Regina Giblin CVD Clinical Development Coordinator"

Transcription

1 CVD Risk of Hypertension Regina Giblin CVD Clinical Development Coordinator

2

3 CVD Clinical Development Coordinator In-house education for your team: Regina Giblin Often interactive with questions and case studies throughout Facilitated discussions & reflection Case studies Individual practice (ECG reading) worksheets, practice ECG s Quizzes Presentations Group Work Individual work or in pairs

4 2020 VISION Fewer people die early or suffer from cardiovascular disease (CVD) People have lower risk factors, helping prevent CVD Fewer people die of heart attacks, and out of hospital cardiac arrest survival rate increases from below 10% All people with cardiovascular disease and cardiac conditions get the information, guidance and support they need

5 Risk Factors Increase our likelihood of developing Cardiovascular Disease Q: Are you able to identify the CVD Risk Factors?

6

7 Tackling High Blood Pressure Better prevention Better detection Better management People from the most deprived areas are 30% more likely than the least deprived to have high blood pressure

8 Hypertension Better Prevention Better Detection Better Management

9 What Is Blood Pressure? The pressure of blood in the arteries Systolic pressure Diastolic pressure What is a normal blood pressure?

10 BP High- So What? Major risk factor for strokes, heart attacks, heart failure, chronic kidney disease, cognitive decline and premature death. Untreated hypertension can cause vascular and renal damage leading to a treatment-resistant state Each 2 mmhg rise in systolic blood pressure associated with increased risk of mortality: 7% from heart disease 10% from stroke.

11 Hypertension Hypertension is common in the UK population Prevalence influenced by age and lifestyle factors and may increase with ageing population Over one quarter of the adult population in the UK have hypertension ½ are not receiving treatment for their Hypertension Half of those over 60 years have hypertension

12 It s All Atheroma Increased Pressure Turbulent Flow Endothelial Damage Development of Atheroma

13 Tower Hamlets CCG 22,835 Adults with diagnosed HTN 7.8% of the population registered with a GP however expected prevalence of hypertension in TH was 16.9%, meaning that 9.2% or 27,000 adults could have hypertension that has not been diagnosed

14 Causes of Hypertension In 95% of cases there is no identifiable cause of hypertension and it relates to lifestyle and genetic factors

15 Causes Primary Hypertension: no identifiable cause, relates to lifestyle, genetic makeup (95% cases) Secondary Hypertension: underlying cause such as renal disease, endocrine, pregnancy, adrenal gland disease Malignant Hypertension : 1% of essential (primary) and secondary will develop rapidly rising or very high BP that threatens end organ damage requires urgent action.

16 Diagnosis If the clinic blood pressure is 140/90 mmhg or higher, offer ambulatory blood pressure monitoring (ABPM) to confirm the diagnosis of hypertension. (HBPM is a suitable alternative to ABPM)

17 Correct Cuff Size? Too small a cuff on a large arm leads to over-reading Too large a cuff on smaller arm underestimation of BP

18 Ambulatory BP Monitoring When using the following to confirm diagnosis, ensure: at least two measurements per hour during the person s usual waking hours between 0800 and 2200hrs Use the average of at least 14 measurements to confirm diagnosis DRIVING and ABPM

19 Applying the monitor for ABPM Manually check the pulse Measure the patients blood pressure in both arms Measure the circumference of the patients upper arm (without clothing) halfway between the tip of the shoulder and the elbow Do 2 BP readings with the ABPM before the patient leaves the clinic

20 Additional benefits of ABPM Assessment of BP variability Diagnosis and on-going assessment of white coat hypertension or effect Evaluation of drug resistant hypertension Determining efficacy of drug treatment over 24 hours Diagnosis and treatment of hypertension in pregnancy Evaluation of symptomatic hypotension

21 Daytime & Night Time Set awake period when initially entering patient details and during the night hourly readings will allow sleep You will need a minimum of 14 daytime BP readings for accurate diagnosis and setting the intervals at every 30 minutes in the day will normally allow this

22 Dipping Status Normal circadian rhythm allows for a nocturnal drop in blood pressure of >10% If a BP does not drop ( non dipper) or the drop is >20% (extreme dipper), there is evidence that there may be increased risk of CVD (European Society of Hypertension,2013)

23 Home BP Monitoring

24 Home BP Monitoring Two consecutive seated measurements, at least 1 minute apart Blood Pressure is recorded twice daily (ideally morning and evening) Record for at least 4 days and preferably for a week Measurements on the first day are discarded and average value of all remaining is used.

25 Applying the Monitor In general use non dominant arm, unless clinical reason not to do so But use arm with higher measurement if there is a difference of >20mmHg for systolic pressure or >10mmHg for diastolic pressure between the 2 arms on 2 measurements A difference in BP of>20/10mmhg may be sign of underlying problem such as main artery stenosis to that arm or dissection of subclavian artery may need specialist investigation

26 Irregular Pulse If pulse is irregular for example in atrial fibrillation, multiple clinic readings are needed using a manual sphygmomanometer to diagnose hypertension

27 Definition of Hypertension Stage 1 Hypertension: Clinic BP is 140/90 mmhg or higher and ABPM or HBPM average is 135/85 mmhg or higher. Stage 2 Hypertension: Clinic BP 160/100 mmhg is or higher and ABPM or HBPM daytime average is 150/95 mmhg or higher. Severe Hypertension: Clinic BP is 180 mmhg or higher or Clinic diastolic BP is 110 mmhg or higher.

28 Day Time Drop If BP drops during the day, consider postural hypotension Patients with hypertension associated with a systolic drop of >20mmHg or diastolic drop of >10mmHg when standing should not be treated with antihypertensives, and may need specialist referral (BJPCN Vol10,Issue 3 Oct-Dec 2013)

29 Treatment Offer Antihypertensive Drug Treatment to people: who have Stage 1 hypertension (CBP140/90) are aged under 80 and have high CV risk, diabetes, target organ damage, renal disease, established CVD. who have Stage 2 hypertension (CBP160>100) at any age HIGH CV risk: 10 year CVD risk over 20% (utilising a tool such as QRISK2)

30 CV Risk &Target Organ Damage Use a formal estimation of cardiovascular risk to discuss prognosis and healthcare options with people with hypertension. For all people with hypertension offer to: test urine for presence of protein take blood to measure glucose, electrolytes, creatinine, estimated glomerular filtration rate and cholesterol examine fundi for hypertensive retinopathy arrange a 12-lead ECG

31 Treatment If aged under 40 with stage 1 hypertension and without evidence of target organ damage, cardiovascular disease, renal disease or diabetes, consider: specialist evaluation of secondary causes of hypertension further assessment of potential target organ damage

32 Specialist Referral Secondary Hypertension suspected Those aged <40 assessment of end organ damage/secondary causes Suspect Phaeochromocytoma Labile BP headache sweating postural hypotension Accelerated Hypertension BP >180/110 papilledema and or retinal haemorrhages

33 CBPM 140/90 mmhg & ABPM/HBPM 135/85 mmhg Stage 1 hypertension CBPM 160/100 mmhg & ABPM/HBPM 150/95 mmhg Stage 2 hypertension Care Pathway If target organ damage present or 10- year cardiovascular risk > 20% Offer antihypertensive drug treatment If younger than 40 years Consider specialist referral Offer lifestyle interventions Offer patient education and interventions to support adherence to treatment Offer annual review of care to monitor blood pressure, provide support and discuss lifestyle, symptoms and medication

34 Aged under 55 years A Aged over 55 years or black person of African or Caribbean family origin of any age C Step 1 Summary of antihypertensive drug treatment A + C A + C + D Resistant hypertension A + C + D + consider further diuretic3, 4 or alpha- or beta-blocker5 Consider seeking expert advice Step 2 Step 3 Step 4 Key A ACE inhibitor or low-cost angiotensin II receptor blocker (ARB)1 C Calcium-channel blocker (CCB) D Thiazide-like diuretic See slide notes for details of footnotes 1-5

35

36 Anti-Hypertensives ACE inhibitors Ramipril, Lisinopril, Perindopril Angiotensin receptor blockers Losartan, Candesartan, Valsartan, Irbesartan These drugs block an enzyme called angiotensin which then allows blood vessels to relax and widen, which lowers blood pressure. People on these drugs will need regular blood tests to check their kidney function and potassium levels, as well as regular BP checks.

37 Anti-Hypertensives Calcium Channel blockers Amlodipine. You need a regular flow of calcium into the cells of your heart muscle to contract normally. Calcium channel blockers reduce the amount of calcium entering the muscle cells of the arteries, causing them to relax and widen. As a result, BP falls. Common side effects: swollen ankles, headaches, nausea.

38 Anti-Hypertensives Diuretics (water tablets) Indapamide, bendroflumethiazide, furosemide. Diuretics act on the kidneys to increase the output of water and salt in the urine. They remove excess fluid from the body. They can cause your blood vessels to relax and dilate which can lead to a fall in BP. People on these medications will also need renal function and potassium levels checked regularly.

39 Monitoring Use clinic blood pressure measurements to monitor response to treatment. Aim for target blood pressure below: 140/90 mmhg in people aged under /90 mmhg in people aged 80 and over

40 Hypertension Targets for Diabetics Set a target blood pressure < 130/80 mmhg for people with kidney, eye or cardiovascular damage. For people with diabetes, without target organ damage set a target of <140/80mmHg (NICE 2014: Managing blood pressure in Type 2 diabetes)

41 Indications for Referral Resistant HTN Multiple adverse reactions to HTN meds Persistent non adherence Complex prescribing due to co-morbidities (e.g. CKD and ACE/ARB) Accelerated or malignant HTN Suspected secondary HTN HTN <40yrs

42 Adherence Long term persistence is known to be low. Dutch study found only 39% of patients used their medication continuously during the 10yr follow up. 22% temporarily discontinued and restarted treatment 39% discontinued treatment permanently. Check with patient and prescribing records at all HTN reviews.

43 Patient Education Provide: information about benefits of drugs and side effects details of patient organisations an annual review of care

44 Lifestyle Recommendations Offer guidance and advice about: Diet (including sodium and caffeine intake) Exercise Alcohol consumption Smoking

45 Lifestyle Modifications- Effects on Blood Pressure Modifications* Recommendation Approximate SBP Reduction Reduce weight Maintain normal body weight (BMI of kg/m 2 ) 3-20 mm Hg Adopt DASH diet Reduce dietary sodium Rich in fruit, vegetables and lowfat dairy; reduced saturated and total fat content 8-14 mm Hg <100 mmol (2.4g)/day 2-8 mm Hg Increase physical activity Aerobic activity >30 min/day most days of the week 4-9 mmhg Moderate alcohol consumption Men: < 2 drinks/day Women: < 1 drink/day 2-4 mm Hg Chobanian AV et al., JAMA 2003; 289: Blumenthal JA et al., Arch Intern Med. 2000; 160:

46 Question What is the maximum recommended daily intake of salt? 6 grams

47 Salt High salt intake linked with hypertension Do not use Reduced Sodium Supplements as they have an elevated potassium Common high salt foods include:- Cereals Bread Processed meats/foods Soups and sauces (tinned and packet) Crisps and snacks

48 Summary Blood pressure control key element of CVD risk management Good technique essential Likely to need combination therapy Lifestyle important Education Supported self-management

49 Case Scenario Danny Presentation Danny is a 39-year-old black male of Caribbean family origin. He presents to you with a sore ankle after going over on it. Medical history Danny has no significant past medical history. Previous presentations have been related to coughs and colds. He smokes 25 cigarettes a day, alcohol consumption around 20 units/week and has done for 18 years. He works shifts and says that he considers his diet to be unhealthy as a result.

50 Case Scenario Danny On examination You conclude that Danny s ankle is sprained. As part of your routine examination you measure his blood pressure. The first measurement in his left arm is 150/92 mmhg, the second measurement in his right arm is 149/91 mmhg and the third measurement in his left arm is 151/92 mmhg. Question 1: What would you do next?

51 Case Scenario Danny Answer 1: You would record Danny s clinic blood pressure as 149/91 mmhg. In order to diagnose hypertension, you organise ambulatory blood pressure monitoring (ABPM) to confirm a diagnosis of hypertension. When organising this you ensure that at least two measurements per hour are taken during Danny s usual waking hours. You would use the average value of at least 14 measurements taken during Danny s usual waking hours to confirm a diagnosis of hypertension. At the same time you would also carry out investigations for target organ damage (such as left ventricular hypertrophy, chronic kidney disease and hypertensive retinopathy).

52 Case Scenario Danny You would: test for the presence of protein in the urine by sending a urine sample for estimation of the albumin:creatinine ratio and test for haematuria using a reagent strip take a blood sample to measure plasma glucose, electrolytes, creatinine, estimated glomerular filtration rate, serum total cholesterol and HDL cholesterol examine the fundi for the presence of hypertensive retinopathy arrange for a 12-lead electrocardiograph to be performed.

53 Answer 1 (continued) Case Scenario Danny You would also carry out and a formal assessment of cardiovascular risk (Danny s clinic blood pressure must be used in the calculation of cardiovascular risk) using a cardiovascular risk assessment tool, in line with the recommendations on Identification and assessment of CVD risk in Lipid modification (NICE clinical guideline 67). Additionally, you would ascertain information about lifestyle in areas such as diet, exercise, alcohol, smoking and caffeine consumption and dietary sodium intake and offer appropriate lifestyle advice. Given the history provided you ensure that you include lifestyle advice about smoking, alcohol consumption and diet and exercise Record the results of the investigations and assessments in Danny s notes.

54 Case Scenario Danny Question 2: ABPM indicates that Danny s daytime average blood pressure is 147/89 mmhg. There is no evidence of target organ damage, cardiovascular disease, renal disease or diabetes. You identify a 10-year cardiovascular risk equivalent to under 20%. With this information, what is your diagnosis and what would you do next?

55 Answer 2: Case Scenario Danny You would diagnose stage 1 hypertension and consider referring Danny for a specialist evaluation of secondary causes of hypertension and a more detailed assessment of potential target organ damage. If you had not already done so you would also assess cardiovascular risk and offer to test for target organ damage You would use the results of the initial cardiovascular risk assessment to discuss prognosis and healthcare options with Danny. You would also offer Danny lifestyle advice in accordance with the guideline on areas such as diet (including sodium and caffeine intake), exercise, alcohol consumption and smoking.

56 Case Scenario Danny Question 3 The results of the tests you arranged (presence of protein in the urine, estimation of the albumin:creatinine ratio, haematuria, plasma glucose, electrolytes, creatinine, estimated glomerular filtration rate, cholesterol, hypertensive retinopathy, 12-lead electrocardiograph) have been returned. All are normal with the exception of cholesterol which was total cholesterol = 5.6mmol/L, HDL cholesterol 1.1mmol/L. What would you consider next in order to help you decide on the best management strategy for Danny?

57 Case Scenario Danny Answer 3 You would consider seeking specialist evaluation of secondary causes of hypertension and a more detailed assessment of potential target organ damage. This is because 10-year cardiovascular risk assessments can underestimate the lifetime risk of cardiovascular events in these people. Additionally, people under 40 years with stage 1 hypertension are less likely to have overt evidence of target organ damage or vascular disease. You decide to refer Danny for the specialist assessment.

58 Case Scenario Danny Question 3 The results of the specialist assessment are returned. There are no secondary causes of hypertension; however, he was noted to have left ventricular hypertrophy and early evidence of impaired diastolic relaxation on his echocardiogram. The report suggests that these changes are most likely related to hypertension. Thus, Danny has evidence of target organ damage. What would you do next?

59 Case Scenario Danny Answer 3 You would offer Danny treatment with a calcium-channel blocker, for example amlodipine. You would also offer him appropriate information about the drug and unwanted side effects. You would see the results of the more detailed cardiovascular risk assessment, which included the cholesterol levels to discuss prognosis and healthcare options with Danny

60 Case Scenario Danny As appropriate, you would repeat the lifestyle advice that was given in answers 1 and 2 in accordance with the guideline on areas such as diet (including sodium and caffeine intake), exercise, alcohol consumption and smoking. As Danny s cholesterol level is marginally elevated, you would also enquire about the fat content of his diet and recommend that he reduces his fat intake. You would note that his cholesterol needs rechecking. You would ask Danny to return to your practice in 4 weeks for a review of his blood pressure

61 Case Scenario Danny Question 4 You have previously concluded that Danny s sprained ankle has healed and all swelling had cleared. Danny returns to the clinic and you notice both ankles are very swollen, which are new to him. This is likely to indicate that he is not tolerating his calcium-channel blocker His clinic blood pressure is 135/86 mmhg Would you consider that his blood pressure has been controlled? What would you do next?

62 Case Scenario Danny Answer 4 Danny s blood pressure has been controlled as his clinic blood pressure is now below 140/90 mmhg which is what you were aiming for. However, he was not tolerating the calcium channel blocker. You would change the calcium-channel blocker to a thiazide like diuretic such as indapamide 2.5 mg once daily. You would arrange for him to return to clinic to check his blood pressure again in 4 weeks.

63 Resources for You and Your Patient BHF Resources:- Blood pressure. 10 minutes to change your life high blood pressure How to control it (South Asians) Factfile for GP s on home monitoring Risking it DVD on CHD risk factors other Resources:- British Hypertensive Society up to date information, including guidance on ABPM, patient information, therapeutics and nutritional advice. Blood Pressure UK

64 How to Order All our resources are free to order, although we do ask for a donation if you can afford one Web: bhf.org.uk/publications Call: orderline@bhf.org.uk

65 Heart Helpline We're here to help you, whether you're calling about yourself or someone you care about. Our cardiac nurses and heart health advisors are on hand to help you answer any questions or concerns you have about heart health and heart conditions.

66 Join the BHF Alliance Benefits for members A valued connection with the BHF Annual learning and development allowance Access to learning and development information Access to a bespoke online discussion forum Access to Alliance regional and national events Access to BHF resources Your BHF e-newsletters Free subscription to the Heart Matters Membership and magazine Visit bhf.org.uk/alliance and complete the online application form today

67 Heart Matters Our free service offers support and information for people looking to improve their heart health. As a member you'll benefit from: a welcome pack access to our online community regular issues of Heart Matters magazine free support a dedicated Helpline access to a members' area

68

69 Questions?

Hypertension Clinical case scenarios for primary care

Hypertension Clinical case scenarios for primary care Hypertension Clinical case scenarios for primary care Implementing NICE guidance August 2011 NICE clinical guideline 127 What this presentation covers Five clinical case scenarios, including: presentation

More information

5.2 Key priorities for implementation

5.2 Key priorities for implementation 5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail

More information

Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127

Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127 Hypertension in adults: diagnosis and management Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured. Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.

More information

MPharmProgramme. Hypertension (HTN)

MPharmProgramme. Hypertension (HTN) MPharmProgramme Hypertension (HTN) Slide 1 of 30 Overview Definition Prevalence Type Causes Diagnosis Management Patients perspective Slide 2 of 30 Definition It is not a disease! So what is it? What two

More information

NICE BHS Hypertension guidelines 2011 update

NICE BHS Hypertension guidelines 2011 update NICE BHS Hypertension guidelines 2011 update Review for clinicians Sept 2011 Mark Thomas West Midlands Hypertension Centre Heart of England NHS Trust www.wmhc.co.uk mark.thomas@heartofengland.nhs.uk Full

More information

Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION.

Dr Diana R Holdright. MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION. Dr Diana R Holdright MD, FRCP, FESC, FACC, MBBS, DA, BSc. Consultant Cardiologist HYPERTENSION www.drholdright.co.uk Blood pressure is the pressure exerted on the walls of the arteries when the heart pumps;

More information

Primary hypertension in adults

Primary hypertension in adults Primary hypertension in adults NICE provided the content for this booklet which is independent of any company or product advertised Hypertension Welcome NICE published an updated guideline on the diagnosis

More information

Incidental Findings; Management of patients presenting with high BP. Phil Swales

Incidental Findings; Management of patients presenting with high BP. Phil Swales Incidental Findings; Management of patients presenting with high BP Phil Swales Consultant Physician Acute & General Medicine University Hospitals of Leicester NHS Trust Objectives The approach to an incidental

More information

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011) What s new in hypertension? NICE has issued an updated Clinical

More information

CLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension.

CLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension. GUIDELINE CLINICAL GUIDELINE Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension. TITLE Management of adult patients referred to South

More information

North of Tyne and Gateshead Guidelines for Management and Diagnosis of Hypertension Reviewed August 2017

North of Tyne and Gateshead Guidelines for Management and Diagnosis of Hypertension Reviewed August 2017 North of Tyne and Gateshead Guidelines for Management and Diagnosis of Hypertension Reviewed August 2017 An electronic version of this document can also be viewed / downloaded from the North of Tyne and

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None Dr Narender Goel MD (Internal Medicine and Nephrology) drnarendergoel@gmail.com Financial Disclosure: None, Conflict of Interest: None 12 th December 2013, New York Visit us at: http://kidneyscience.info/

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

Cardiac Pathophysiology

Cardiac Pathophysiology Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

CKD & HT. Anne-Marie Angus

CKD & HT. Anne-Marie Angus CKD & HT Anne-Marie Angus Hypertension definitions Persisting BP >140/90 and HBPM >135/85 Stage 1 >140/90 (HBPM >135/85) Stage 2 >160/100 (HBPM >150/90) Severe >180/100 White coat HT Why treat? A major

More information

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu

More information

High blood pressure (Hypertension)

High blood pressure (Hypertension) High blood pressure (Hypertension) Information for patients from the Department of Renal (Kidney) Medicine This leaflet is not meant to replace the information discussed between you and your doctor, but

More information

Summary of recommendations

Summary of recommendations Summary of recommendations Measuring blood pressure (BP) Use the recommended technique at every BP reading to ensure accurate measurements and avoid common errs. Pay particular attention to the following:

More information

hypertension Head of prevention and control of CVD disease office Ministry of heath

hypertension Head of prevention and control of CVD disease office Ministry of heath hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension

More information

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to

Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to Hypertension The normal radial artery blood pressures in adults are: Systolic arterial pressure: 100 to 140 mmhg. Diastolic arterial pressure: 60 to 90 mmhg. These pressures are called Normal blood pressure

More information

Managing Hypertension in 2016

Managing Hypertension in 2016 Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu

More information

Overview. NOT A REPETION OF LOCAL GUIDELINE Dr Diviash Thakrar

Overview. NOT A REPETION OF LOCAL GUIDELINE Dr Diviash Thakrar Overview 1. Why hypertension is important? 2. What are basic principles in treatment? 3. Different ways of measuring 4. Hypercholesterolemia NOT A REPETION OF LOCAL GUIDELINE CVD risk factors? Non modifiable

More information

Talking about blood pressure

Talking about blood pressure Talking about blood pressure Mrs Khan 56 BP 158/99 BMI 32 Total cholesterol 5.4 (HDL 0.8) HbA1c 43 She has been promising to do more exercise and eat more healthily for the last 2 years but her weight

More information

major public health burden

major public health burden HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing

More information

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

Prevention of Heart Failure: What s New with Hypertension

Prevention of Heart Failure: What s New with Hypertension Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults

More information

Management of Hypertension

Management of Hypertension Clinical Practice Guidelines Management of Hypertension Definition and classification of blood pressure levels (mmhg) Category Systolic Diastolic Normal

More information

INTRODUCING HIGH BLOOD PRESSURE

INTRODUCING HIGH BLOOD PRESSURE INTRODUCING HIGH BLOOD PRESSURE Helping you to lower your blood pressure BLOOD PRESSURE UK About this booklet This is one of a series of booklets produced by Blood Pressure UK, to help people with high

More information

Genetic factors. A number of genetic factors or interactions between genes play a major role in essential hypertension.

Genetic factors. A number of genetic factors or interactions between genes play a major role in essential hypertension. Hypertension Blood pressure is a measurement of the force against the walls of your arteries as your heart pumps blood through your body. Hypertension is another term used to describe high blood pressure.

More information

Impact of Recent Hypertension Guidelines on Clinical Practice

Impact of Recent Hypertension Guidelines on Clinical Practice C H A P T E R 144 Impact of Recent Hypertension Guidelines on Clinical Practice NK Soni, VB Jindal The movement towards evidence-based healthcare has been gaining ground quickly over the past few years,

More information

High blood pressure and stroke

High blood pressure and stroke Call the Stroke Helpline: 0303 3033 100 or email: info@stroke.org.uk High blood pressure and stroke High blood pressure usually has no symptoms, but it is a contributing factor in around half of all strokes,

More information

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Quinn Capers, IV, MD, FACC, FSCAI Assistant Professor of Medicine Associate Dean for Admissions Do Racial Differences Really Exist

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept Continents 1- introduction 2- classification/definition 3- classification/etiology 4-etiology in both categories 5- complications

More information

GETTING THE MOST FROM BLOOD PRESSURE MEDICINES

GETTING THE MOST FROM BLOOD PRESSURE MEDICINES GETTING THE MOST FROM BLOOD PRESSURE MEDICINES Helping you to lower your blood pressure BLOOD PRESSURE UK About this booklet This is one of a series of booklets produced by Blood Pressure UK, to help people

More information

Preventing and Treating High Blood Pressure

Preventing and Treating High Blood Pressure Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure

More information

What s In the New Hypertension Guidelines?

What s In the New Hypertension Guidelines? American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,

More information

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment

More information

STANDARD treatment algorithm mmHg

STANDARD treatment algorithm mmHg STANDARD treatment algorithm 130-140mmHg (i) At BASELINE, If AVERAGE SBP 1 > 140mmHg If on no antihypertensive drugs: Start 1 drug: If >55 years old / Afro-Caribbean: Calcium channel blocker (CCB) 2 If

More information

Egyptian Hypertension Guidelines

Egyptian Hypertension Guidelines Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

Modern Management of Hypertension

Modern Management of Hypertension Modern Management of Hypertension Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Hypertension Prevalence

More information

HYPERTENSION. Shelby Bublitz Winter Quarter 2015 Cory Ruth NTRS 415A-03 Shelly Truong Professor Owen

HYPERTENSION. Shelby Bublitz Winter Quarter 2015 Cory Ruth NTRS 415A-03 Shelly Truong Professor Owen HYPERTENSION Shelby Bublitz Winter Quarter 2015 Cory Ruth NTRS 415A-03 Shelly Truong Professor Owen What exactly is HYPERTENSION? Blood pressure is affected either by peripheral resistance or cardiac output.

More information

HYPERTENSION: ARE WE GOING TOO LOW?

HYPERTENSION: ARE WE GOING TOO LOW? HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%

More information

Update in Hypertension

Update in Hypertension Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded

More information

From the desk of the: THE VIRTUAL NEPHROLOGIST

From the desk of the: THE VIRTUAL NEPHROLOGIST Hypertension, also referred to as high blood pressure or HTN, is a medical condition in which the blood pressure is chronically elevated. It is a very common illness. One out of three American adults has

More information

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina

More information

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be

More information

Update on Current Trends in Hypertension Management

Update on Current Trends in Hypertension Management Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student

More information

Modern Management of Hypertension: Where Do We Draw the Line?

Modern Management of Hypertension: Where Do We Draw the Line? Modern Management of Hypertension: Where Do We Draw the Line? Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Blood Pressure

More information

New Hypertension Guidelines. Kofi Osei, MD

New Hypertension Guidelines. Kofi Osei, MD New Hypertension Guidelines Kofi Osei, MD None Disclosures Objectives The new blood pressure definitions and cardiovascular risk The role to time and location in the diagnosis of hypertension Apply evidence-based

More information

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine

More information

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of

More information

Hypertension Update Background

Hypertension Update Background Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison

More information

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes

More information

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals

More information

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure 신장환자의혈압조절 K/DOQI Clinical practice guidelines on Hypertension and Antihypertensive agents in CKD 나기영 Factors involved in the regulation of blood pressure Renal function curve MAP (mmhg) Central role of

More information

Hypertension Update. Aaron J. Friedberg, MD

Hypertension Update. Aaron J. Friedberg, MD Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline

More information

Blood Pressure Acre Surgery Diviash Thakrar

Blood Pressure Acre Surgery Diviash Thakrar Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise

More information

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B) Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed

More information

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card

More information

Medical Advice for Athletes with High or Normal-High Blood Pressure (Hypertension)

Medical Advice for Athletes with High or Normal-High Blood Pressure (Hypertension) Medical Advice for Athletes with High or Normal-High Blood Pressure (Hypertension) Created by Dr. Maria-Carmen Adamuz, Consultant Cardiologist. Aug 2017. WHAT IS HYPERTENSION? Blood pressure (BP) is the

More information

Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN

Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups Lisa Ivy APRN The 2017 Guideline is an Update to JNC7 New information regarding BP related risk of CVD Ambulatory BP monitoring

More information

Guideline scope Hypertension in adults (update)

Guideline scope Hypertension in adults (update) NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Hypertension in adults (update) This guideline will update the NICE guideline on hypertension in adults (CG127). The guideline will be

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu Indicator area: Pulse rhythm assessment for AF Indicator: NM146 Date: June 2017 Introduction There is evidence

More information

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313) University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,

More information

Hypertension. Penny Mosley MRPharmS

Hypertension. Penny Mosley MRPharmS Hypertension Penny Mosley MRPharmS Outline of presentation Introduction to hypertension Physiological control of arterial blood pressure What determines our bp? What determines the heart rate? What determines

More information

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between

More information

Objectives. Describe results and implications of recent landmark hypertension trials

Objectives. Describe results and implications of recent landmark hypertension trials Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships

More information

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these

More information

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive

More information

Module 3.2. Management of hypertension at primary health care

Module 3.2. Management of hypertension at primary health care Module 3.2 Management of hypertension at primary health care What s inside Introduction Learning outcomes Topics covered Competency Teaching and learning activities Background information Introduction

More information

Dudley Hypertension Pathway. Presented for discussion, approval and ratification to

Dudley Hypertension Pathway. Presented for discussion, approval and ratification to e Dudley Hypertension Pathway Document Description Document Type Clinical Pathway Service Application Diagnosis and Management Version 2.0 Ratification date May 2016 Review date May 2018 Lead Author(s)

More information

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN** Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits

More information

How Low Do We Go? Update on Hypertension

How Low Do We Go? Update on Hypertension How Low Do We Go? Update on Beth L. Abramson, MD, FRCPC, FACC As presented at the University of Toronto s Saturday at the University Session (September 2003) Arecent World Health Organization report states

More information

Dr Doris M. W Kinuthia

Dr Doris M. W Kinuthia Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of

More information

Medicines for high blood pressure

Medicines for high blood pressure Patient Information: Medicines Medicines for high blood pressure Health & care information you can trust The Information Standard Certified Member Working together for better patient information What is

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS? HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL

More information

Renal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician.

Renal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician. Renal Disease through the Ages: From Childbearing years to Old Age Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician. Learning Outcomes: Understand the presentation of renal

More information

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult

More information

Approach to patient with hypertension. Dr. Amitesh Aggarwal

Approach to patient with hypertension. Dr. Amitesh Aggarwal Approach to patient with hypertension Dr. Amitesh Aggarwal Definition A systolic blood pressure ( SBP) >139 mmhg and/or A diastolic (DBP) >89 mmhg. Based on the average of two or more properly measured,

More information

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs Blood Pressure Normal = sys

More information

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati CHAPTER-I CARDIOVASCULAR SYSTEM Hypertension SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati Hypertension

More information

Five chapters 1. What is CVD prevention 2. Why is CVD prevention needed 3. Who needs CVD prevention 4. How is CVD prevention applied 5. Where should CVD prevention be offered Shorter, more adapted to clinical

More information

What is hypertension?

What is hypertension? HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90

More information

CHALLENGES OF HYPERTENSION IN THE COALFACE

CHALLENGES OF HYPERTENSION IN THE COALFACE CHALLENGES OF HYPERTENSION IN THE COALFACE Y VERIAVA CENTRE FOR RURAL HEALTH SCHOOL OF CLINICAL MEDICINE FACULTY OF HEALTH SCIENCES UNIVERSITY OF WITWATERSRAND SYSTOLIC AND DIASTOLIC BLOOD PRESSURES (BP)

More information

Role of Minerals in Hypertension

Role of Minerals in Hypertension Role of Minerals in Hypertension Lecture objectives By the end of the lecture students will be able to Define primary and secondary hypertention and their risk factors. Relate role of minerals with hypertention.

More information

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant

More information

Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities

Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities Summary After four years of NHS Health Checks, Barnsley has access to aggregated data on over 47,000 people. This data was analysed

More information